title: The vigor of defense against non-self: potential superiority of allorestricted T cells in immunotherapy of cancer?
abstract: Men and sharks are both jawed vertebrates at the top of the food chain. Sharks are the first extant to develop adaptive immunity preserved to man throughout jawed vertebrates. We hypothesize here, that T cell receptor/major histocompatibility complex (TCR/MHC) interactions developed as the defense mechanism of carnivors against takeover by their victims' cells derived pathogens. Germline encoded TCR segments have been conserved in evolution, providing the MHC bias of TCR. Ancestor genes of MHC polymorphisms may have first developed as a mating preference system, that later in evolution provided host immune responses destroying infectious non-self, yet maintaining tolerance to self. Pathogens may thus have simultaneously selected for alloimmunity. Allorejection has been observed in sharks and men. Cannibalism is a common ecological interaction in the animal kingdom, especially prevalent in aquatic communities; it favors selection of intraspecies allo responses for defense of self integrity. Alloreactive T cells do not undergo negative selection of strong TCR/MHC interactions; thus, they react stronger than self-MHC recognizing T cells. High levels of genetic diversity at MHC genes play a critical role in protecting populations of vertebrate species from contagious cells displaying stemness and homing features, including cancer cells. Recognition of self-MHC fails especially in diseases, which predominantly arise with age and after the peak of reproduction, e.g., cancer. So far, the treatment of malignant disease with autologous T cells has widely failed. Allorecognition constitutes an extremely powerful mechanism in evolution, which may be employed in immunotherapy of cancer by MHC-disparate, e.g., haploidentical transplantation and consecutive treatment with T cells from the donor parents recognizing tumor selective peptides presented by the non-inherited haplotype on the tumor.
authors: Laboratory of Transplantation Biology, Children's Cancer Research Center and Department of Pediatrics, Kinderklinik München Schwabing, Technische Universität München München, Germany.
authors: Stefan
authors: S
authors: Burdach
authors: Hans-Jochem
authors: HJ
authors: Kolb
keywords: TCR/MHC evolution; adaptive immunity; allorestricted T cells; cellular immunity; haploidentical transplantation; immunotherapy of cancer; tumor therapy
references: Nature. 1998 Aug 20;394(6695):744-51
references: 9723614
references: Nature. 1992 Nov 26;360(6402):300-1
references: 1448144
references: J Exp Med. 1977 Mar 1;145(3):508-22
references: 233899
references: Nat Rev Immunol. 2012 Mar 22;12(4):269-81
references: 22437939
references: Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):6924-6
references: 10860947
references: Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14350-5
references: 12388781
references: Zh Evol Biokhim Fiziol. 2002 Sep-Oct;38(5):442-51
references: 12575647
references: Nature. 1991 Aug 15;352(6336):619-21
references: 1865924
references: Trends Immunol. 2013 Feb;34(2):90-8
references: 23031830
references: Nat Rev Immunol. 2013 Feb;13(2):88-100
references: 23348415
references: Clin Cancer Res. 2013 Apr 15;19(8):1917-9
references: 23444214
references: Nat Rev Immunol. 2010 Aug;10(8):543-53
references: 20651744
references: Trends Immunol. 2004 Jan;25(1):11-6
references: 14698279
references: Immunol Today. 1999 Apr;20(4):180-3
references: 10203716
references: Nat Rev Immunol. 2007 Dec;7(12):942-53
references: 18007679
references: Dev Biol. 2002 Feb 1;242(1):1-14
references: 11795936
references: FASEB J. 2002 Jun;16(8):842-8
references: 12039866
references: J Theor Biol. 1998 Aug 7;193(3):429-44
references: 9735271
references: Immunity. 1997 Jan;6(1):1-11
references: 9052832
references: Immunity. 2011 Oct 28;35(4):526-35
references: 21962492
references: Immunol Cell Biol. 1997 Apr;75(2):193-6
references: 9107575
references: Mamm Genome. 2011 Feb;22(1-2):83-90
references: 20963591
references: Q Rev Biol. 2004 Dec;79(4):359-82
references: 15669770
references: Blood. 1990 Dec 15;76(12):2462-5
references: 2265242
references: Dev Comp Immunol. 1999 Mar-Apr;23(2):107-11
references: 10227478
references: Ann Oncol. 2000 Nov;11(11):1451-62
references: 11142486
references: Immunol Rev. 2004 Apr;198:25-35
references: 15199952
references: Cell. 2005 Dec 29;123(7):1351-60
references: 16377573
references: Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16221-6
references: 17911263
references: Nat Immunol. 2002 Dec;3(12):1124-5
references: 12447367